Under chemotherapy selective pressure, tumor cells can become “addicted” to Bcl-2 expression for survival, so an obvious strategy to overcome this resistance mechanism may be the use of Bcl-2 inhibitors (reviewed in [212,213]). Here, BCL2 is linked to neoplasm.